Brokers Offer Predictions for Cross Country Healthcare, Inc.’s Q4 2023 Earnings (NASDAQ:CCRN)

Cross Country Healthcare, Inc. (NASDAQ:CCRNGet Rating) – Equities research analysts at Oppenheimer raised their Q4 2023 EPS estimates for shares of Cross Country Healthcare in a note issued to investors on Wednesday, September 14th. Oppenheimer analyst M. Wiederhorn now forecasts that the business services provider will post earnings of $0.81 per share for the quarter, up from their previous estimate of $0.66. The consensus estimate for Cross Country Healthcare’s current full-year earnings is $4.70 per share.

Several other equities analysts have also recently commented on CCRN. Barrington Research dropped their target price on shares of Cross Country Healthcare to $40.00 in a research report on Monday, August 22nd. Credit Suisse Group dropped their target price on shares of Cross Country Healthcare from $28.00 to $26.00 and set a “neutral” rating for the company in a research report on Thursday, June 9th. Finally, Benchmark boosted their target price on shares of Cross Country Healthcare from $37.00 to $42.00 and gave the company a “buy” rating in a research report on Thursday. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, Cross Country Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $33.75.

Cross Country Healthcare Price Performance

Shares of NASDAQ:CCRN opened at $29.62 on Friday. The firm has a 50 day moving average of $25.56 and a 200-day moving average of $21.63. The stock has a market capitalization of $1.13 billion, a PE ratio of 5.18, a PEG ratio of 0.61 and a beta of 1.03. The company has a current ratio of 2.67, a quick ratio of 2.67 and a debt-to-equity ratio of 0.50. Cross Country Healthcare has a 12 month low of $15.26 and a 12 month high of $30.51.

Insider Activity at Cross Country Healthcare

In related news, CEO John Anthony Martins purchased 4,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 24th. The shares were bought at an average cost of $25.24 per share, with a total value of $100,960.00. Following the acquisition, the chief executive officer now owns 52,039 shares of the company’s stock, valued at approximately $1,313,464.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CEO John Anthony Martins purchased 4,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 24th. The shares were bought at an average cost of $25.24 per share, with a total value of $100,960.00. Following the acquisition, the chief executive officer now owns 52,039 shares of the company’s stock, valued at approximately $1,313,464.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director W Larry Cash purchased 1,500 shares of the firm’s stock in a transaction that occurred on Tuesday, August 30th. The shares were bought at an average cost of $25.60 per share, for a total transaction of $38,400.00. Following the completion of the acquisition, the director now directly owns 177,899 shares in the company, valued at approximately $4,554,214.40. The disclosure for this purchase can be found here. 5.00% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Cross Country Healthcare

Institutional investors have recently added to or reduced their stakes in the business. Congress Asset Management Co. MA grew its holdings in Cross Country Healthcare by 8.0% during the 1st quarter. Congress Asset Management Co. MA now owns 340,754 shares of the business services provider’s stock worth $7,384,000 after acquiring an additional 25,202 shares during the last quarter. First Eagle Investment Management LLC grew its holdings in Cross Country Healthcare by 70.1% during the 1st quarter. First Eagle Investment Management LLC now owns 53,629 shares of the business services provider’s stock worth $1,162,000 after acquiring an additional 22,092 shares during the last quarter. Islay Capital Management LLC bought a new stake in Cross Country Healthcare during the 1st quarter worth approximately $153,000. Russell Investments Group Ltd. grew its holdings in Cross Country Healthcare by 345.4% during the 1st quarter. Russell Investments Group Ltd. now owns 54,873 shares of the business services provider’s stock worth $1,184,000 after acquiring an additional 42,552 shares during the last quarter. Finally, GSA Capital Partners LLP grew its holdings in Cross Country Healthcare by 30.9% during the 4th quarter. GSA Capital Partners LLP now owns 18,523 shares of the business services provider’s stock worth $514,000 after acquiring an additional 4,370 shares during the last quarter. 95.25% of the stock is owned by institutional investors.

About Cross Country Healthcare

(Get Rating)

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company operates in two segments, Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, local nurses, and allied staffing; staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, RPO, and consulting services.

Recommended Stories

Earnings History and Estimates for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.